Severe Asthma ToolkitSevere Asthma Toolkit
HomeAboutSpecific PopulationsRegistriesContributorsContact
Twitter
  • What is Severe Asthma?
    • Overview
    • Definition
    • Prevalence & Burden
    • Pathophysiology
    • Symptoms
    • Severe Asthma Attacks / Exacerbations / Flare-ups
    • Asthma Phenotypes
  • Diagnosis & Assessment
    • Overview
    • Diagnosis Overview
    • Assessment Overview
    • Lung Function Assessments
    • Questionnaires
    • Allergy Assessments
    • Phenotyping
    • Bronchoscopy
    • Imaging
    • Occupational Asthma
  • Management
    • Overview
    • Asthma Education
      • About Severe Asthma
      • Asthma Pathophysiology
      • Medications Education
      • Self-Monitoring
      • Triggers
      • Review
    • Written Action Plans
    • Adherence
    • Inhaler Technique
    • Physical Activity & Exercise
    • Interdisciplinary Approach & Multidimensional Assessment
    • Referral
  • Medications
    • Overview
    • Relievers
    • Preventers / Controllers
    • Add-on Therapies
    • Monoclonal Antibodies
      • Travelling with Monoclonal Antibodies
    • Bronchial Thermoplasty
  • Co-Morbidities
    • Overview
    • Pulmonary & Upper Airways
      • Allergic & Non-Allergic Rhinitis
      • Chronic Rhinosinusitis
      • Dysfunctional Breathing
      • Vocal Cord Dysfunction
      • Chronic Obstructive Pulmonary Disease
      • Bronchiectasis
      • Obstructive Sleep Apnoea
    • Extra-Pulmonary
      • Obesity
      • Anxiety & Depression
      • Gastro-oesophageal Reflux Disease (GORD)
      • Osteoporosis
      • Cardiovascular Disease & Metabolic Disease
  • Living with Severe Asthma
    • Overview
    • Daily Symptom Burden
    • Mental & Emotional Health
    • Intimacy & Relationships
    • Self-Management Support
    • Medication Use & Costs
    • Experience of Care
    • Experience of Asthma Attacks
    • Prognosis
  • Establishing a Clinic
    • Overview
    • Set-up
    • Staffing & Multidisciplinary Team Approach
    • Facilities
    • Delivery Approach
    • Tailored Referrals
    • Evaluation
    • Opportunities for Training & Research
    • Barriers & Hurdles
  • Paediatrics
    • Overview
    • Management in Paediatrics
    • Assessment in Paediatrics
    • Alternative Diagnosis & Co-Morbidities in Paediatrics
    • Psychosocial Issues in Paediatrics
    • Medications in Paediatrics
    • Asthma in the Adolescent Population
  • Resources
    • Overview
    • Clinic Recommendations
    • Infographics
    • Asthma Assessment Resources
    • Systematic & Multidimensional Assessment Resources
      • Airway Components
      • Comorbidity Components
      • Risk Factor Components
    • Translation & Implementation
    • Case Studies
    • Presentations
    • Videos
    • Relevant Links
    • Key References

Bronchiectasis

Home Co-Morbidities Pulmonary & Upper Airways Bronchiectasis
bronchiectasis
Image source: Wikimedia Commons

Bronchiectasis Impacts:

  • Frequent exacerbations
  • Worse airflow limitation

Bronchiectasis refers to the chronic enlargement of the airways, which is associated with chronic cough, expectoration and a tendency to increased infection susceptibility (McShane et al. 2013). Bronchiectasis results from loss of elastin, muscle and cartilage within the lungs, fibrosis of bronchial walls and peribronchial changes. Bronchiectasis can develop as a result of chronic lung disease, following respiratory infection or as a result of primary or secondary immunodeficiency (Bronchiectasis Toolbox).

Prevalence

Prevalence in severe asthma ranges between 24-40% (Porsbjerg et al. 2017), which is markedly higher than ~3% in the mild asthma population. In the general population, bronchiectasis prevalence is higher in females and the elderly (Seitz et al. 2012, Quint et al. 2016).

Diagnosis

Diagnosis is determined using high-resolution CT imaging of the airways. A confounding factor is the detection of dilated airways in severe asthma patients without clinical features of bronchiectasis. In some patients, the radiological findings may represent severe asthma, rather than true bronchiectasis.

Impact on Asthma

Individuals with asthma and comorbid bronchiectasis experience:

  • More frequent exacerbations and hospitalisations (Coman et al. 2018)
  • Worse airflow limitation (Kang et al. 2014)

Bronchiectasis Treatment

Management focuses on airway clearance, using specific physiotherapy techniques, aerobic exercise, and adequate hydration. Inhalation of hyperosmolar agents and low-dose macrolides are also beneficial (Wong et al. 2012). In contrast to asthma attacks / exacerbations, bronchiectasis exacerbations require effective antibiotic therapy, ideally guided by sputum culture (McShane et al. 2013).

Coexisting bronchiectasis and severe asthma may also be associated with concomitant gastro-oesophageal reflux disease (GORD), hypersensitivity to nonsteroidal anti-inflammatory drugs and increased bood eosinophil counts (Coman et al. 2018). Where these factors co-exist, they should also be appropriately managed.

Despite the relatively high prevalence of bronchiectasis in people with severe asthma, there is limited evidence on whether effective management  improves asthma symptoms.

Additional Resources:

  • Bronchiectasis Toolbox – provides a detailed overview of bronchiectasis diagnosis, assessment and management, including informational videos, references and resources
  • ERS Guidelines for the management of adult bronchiectasis – describes appropriate investigation and treatment strategies determind by a systematic review of the literature (Polverino et al. 2017)

     

Previous
Next

Last Updated on February 12, 2019

Generic selectors
Exact matches only
Search in title
Search in content
Search in posts
Search in pages
Filter by Categories

More results...

  • Overview
  • Pulmonary & Upper Airways
    • Allergic & Non-Allergic Rhinitis
    • Chronic Rhinosinusitis
    • Dysfunctional Breathing
    • Vocal Cord Dysfunction
    • Chronic Obstructive Pulmonary Disease
    • Bronchiectasis
    • Obstructive Sleep Apnoea
  • Extra-Pulmonary
    • Obesity
    • Anxiety & Depression
    • Gastro-oesophageal Reflux Disease (GORD)
    • Osteoporosis
    • Cardiovascular Disease & Metabolic Disease
For considerations relevant to the paediatric and adolescent population, please see Alternative Diagnoses & Co-Morbidities in Paediatrics or Asthma in the Adolescent Population

We want to know who accesses the Severe Asthma Toolkit and how it is used. Please complete our survey.

Responses will inform the continued development of the Severe Asthma Toolkit and future translation and implementation activities. Any feedback you provide will be greatly appreciated.

Complete Survey

  • Website Terms of Use
  • Website Survey
© Copyright 2018    CRICOS Provider Number 00109J    The University of Newcastle, Australia